These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7975232)

  • 1. Competitive binding of neutralizing monoclonal and polyclonal IgG to the HA of influenza A virions in solution: only one IgG molecule is bound per HA trimer regardless of the specificity of the competitor.
    Taylor HP; Dimmock NJ
    Virology; 1994 Nov; 205(1):360-3. PubMed ID: 7975232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-2 and viral haemagglutinin expression by influenza-infected cells; the proteins are close but do not cocap.
    Hackett CJ; Askonas BA
    Immunology; 1982 Mar; 45(3):431-8. PubMed ID: 6977485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of rabies virus neutralization.
    Flamand A; Raux H; Gaudin Y; Ruigrok RW
    Virology; 1993 May; 194(1):302-13. PubMed ID: 7683158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monocytes are unable to bind to or phagocytize IgA and IgG immune complexes formed with influenza virus in vitro.
    Scott CB; Ratcliffe DR; Cramer EB
    J Immunol; 1996 Jul; 157(1):351-9. PubMed ID: 8683137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigenic structure of influenza A virus subtype H5 hemagglutinin: mechanism of acquiring stability to monoclonal antibodies in escape-mutants].
    Il'iushina NA; Rudneva IA; Varich NL; Lipatov AS; Webster RG; Kaverin NV
    Mol Gen Mikrobiol Virusol; 2003; (1):40-5. PubMed ID: 12656046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
    Edwards MJ; Dimmock NJ
    J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin.
    Tamura M; Webster RG; Ennis FA
    J Immunol; 1993 Aug; 151(3):1731-8. PubMed ID: 7687637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stoichiometry of binding between monoclonal antibody molecules and the hemagglutinin of influenza virus.
    Poumbourios P; Brown LE; White DO; Jackson DC
    Virology; 1990 Dec; 179(2):768-76. PubMed ID: 1700542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All rabbits immunized with type A influenza virions have a serum haemagglutination-inhibition antibody response biased to a single epitope in antigenic site B.
    Lambkin R; Dimmock NJ
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():889-97. PubMed ID: 9049335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies.
    Varecková E; Mucha V; Wharton SA; Kostolanský F
    Arch Virol; 2003 Mar; 148(3):469-86. PubMed ID: 12607099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative relationships between an influenza virus and neutralizing antibody.
    Taylor HP; Armstrong SJ; Dimmock NJ
    Virology; 1987 Aug; 159(2):288-98. PubMed ID: 3617501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in response among individuals to antigenic sites on the HA protein of human influenza virus may be responsible for the emergence of drift strains in the human population.
    Nakajima S; Nobusawa E; Nakajima K
    Virology; 2000 Aug; 274(1):220-31. PubMed ID: 10936103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Virus-neutralizing properties of rabbit anti-influenzal IgG with a lowered complement-binding and cytophilic activity].
    Tarkhanova IA; Rovnova ZI; Gnevkovskaia TV; Isaeva EI; Kul'berg AIa
    Biull Eksp Biol Med; 1977 Aug; 84(8):188-91. PubMed ID: 907822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.
    Lim AP; Chan CE; Wong SK; Chan AH; Ooi EE; Hanson BJ
    Virol J; 2008 Oct; 5():130. PubMed ID: 18957074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.
    Fleury D; Barrère B; Bizebard T; Daniels RS; Skehel JJ; Knossow M
    Nat Struct Biol; 1999 Jun; 6(6):530-4. PubMed ID: 10360354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valency of antibody binding to virions and its determination by surface plasmon resonance.
    Dimmock NJ; Hardy SA
    Rev Med Virol; 2004; 14(2):123-35. PubMed ID: 15027004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the structure of influenza B hemagglutinin using site-directed mutagenesis.
    Rivera K; Thomas H; Zhang H; Bossart-Whitaker P; Wei X; Air GM
    Virology; 1995 Feb; 206(2):787-95. PubMed ID: 7856092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative investigation of monoclonal and polyclonal antibodies directed against strain-specific and common antigenic sites on influenza H1N1 virus hemagglutinin.
    Drescher J; Verhagen W; Flik J; Stachan R
    Intervirology; 1987; 27(4):205-17. PubMed ID: 2447032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.